AVEO PHARMACEUTICALS INC·4

Feb 5, 7:10 PM ET

Rubin Karuna 4

4 · AVEO PHARMACEUTICALS INC · Filed Feb 5, 2018

Insider Transaction Report

Form 4
Period: 2018-02-01
Rubin Karuna
Senior VP and General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2018-02-01+280,000280,000 total
    Exercise: $3.08Exp: 2028-01-31Common Stock (280,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest in equal monthly installments from March 1, 2018, through February 1, 2022, subject to the Reporting Person's continued service to the Company.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION